Dr. Christian Rolfo is a Professor of Medicine (Hematology and Medical Oncology) and Associate Director for Clinical Research in the Center for Thoracic Oncology at The Tisch Cancer Institute. He has a focus on drug development, lung cancer, other thoracic malignancies, biomarkers, resistant mechanisms discovery, and liquid biopsies.

Dr. Rolfo has held academic appointments at various institutions, including the University of Cordoba, Argentina; University of Antwerp, Belgium; University of Palermo, Italy, and the University of Maryland and Greenbaum Comprehensive Cancer Center where he held the position of Director of Thoracic Medical Oncology and Director of Early Clinical Trials.

He earned his MD at the University of Cordoba School of Medicine, his PhD and Doctor Europaeus in Clinical Oncology and Experimental Research at European University of Palermo, Italy, and an MBA in Hospital and Health Services Management and Organization at Polytechnic University of Valencia, Spain. He completed his residency training in Medical Oncology at the National Cancer Institute in Milan (University of Milan, Italy).

Dr. Rolfo is the President of the International Society of Liquid Biopsy (ISLB) and Deputy chair of the Education Committee at the International Association for Study of Lung Cancer (IASLC). He also served as a member of the Drug Approval & First in Human Commission at the Ministry of Health in Belgium during his time as Phase I Director at Antwerp University. He is actively working on drug development and lung cancer and mesothelioma treatment.

His research is focused on molecular oncology, targeted therapies, and Immunotherapy in thoracic oncology using new techniques in liquid biopsies, specifically in extracellular vesicles and circulating free tumor DNA. He is currently working on the identification of new biomarkers involved in immunotherapy and TKI drug-resistance. Dr. Rolfo can be reached at Mount Sinai West 425 W 59th Street, 8th Floor, New York, NY, 10019 and can be contacted at 212-523-5559.